BOERNE, TX – May 10, 2011 – Stanbio Laboratory, a leader in medical testing and diagnostic devices, is pleased to announce that Mark Rison has accepted the position of Director of Quality for the company. Mr. Rison will lead the Quality Control, Quality Assurance and the Regulatory Affairs departments within Stanbio Laboratory.
Mr. Rison has broad general and technical management expertise gained from his prior experience while he was with Colin Medical Instruments Corp. His well-rounded background includes serving as National Service Manager, Director of Business Development, Vice President and eventually President and COO of Colin Medical Instruments. Prior to joining Colin Medical Instruments, Mr. Rison was Vice President of American Diagnostic Services. He has also acted as a consultant to various hospitals on capital equipment purchases, contract services and biomedical needs. Mr. Rison’s vast experience and training will be an invaluable asset to Stanbio Laboratory.
Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 51st year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.
